Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

IJPRT. 2023; 13(2): 84-100


Solubility Enhancement of Nateglinide by Solid Dispersion and Their Characterization

GOUNIKADI SAI PRAVALLIKA, K. RAMESH,G.VIJAY KUMAR.




Abstract

The aim of the present work is to investigate the possibility of obtaining immediate release tablet of Nateglinide with improved dissolution using Solid dispersion technique. The solubility and dissolution rate of Nateglinide can be enhanced by formulating SDs of Nateglinide with PEG 6000.The solubilization effect of PEG 6000, reduction of particle aggregation of the drug, formation of microcrystalline or amorphous drug, increased wetability and dispersibility, and alteration of the surface properties of the drug particles might be responsible for the enhanced solubility and dissolution rate of Nateglinide from its SD and to some extent in PMs. No endothermic peak of Nateglinide was present in of SDs with PEG 6000 suggesting the absence of crystalline Nateglinide. From FTIR spectroscopy, it was concluded that there was no well defined chemical interaction between Nateglinide and PEG 6000 in SDs and in PMs, as no important new peaks could be observed. The identical composition of Superdisintegrants showed that a substantial shorter time require for disintegration can be obtained and immediate release tablet were prepared. The Nateglinide immediate release tablet (F2) showed 78.72% drug release within first 5 min. and 99.50% drug release with in 30 min. The results showed that the formulation satisfied the objective of fast disintegration, dissolution, % friability, hardness, wetting time, water absorption ratio, ease of administration and safety. Success of the present study recommends a detailed investigation in to in-vivo studies for its effective use in clinical practice.

Key words: Nateglinide, Immediate release tablets, Solid dispersion technique, kinetic study, PEG.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.